Pear VC β 2024 Investments
5 investments dated 2024 Β· listed companies and verified rows first Β· show all
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)Dov Goldstein(Executive Officer)
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesLongitude CapitalOrbiMed+4 more
Abstractive Health provides AI-powered medical record summarization and pre-visit review tools for clinicians.
AI & Machine LearningDigital HealthHealthtech
Vince Hartman(Co-founder & CEO)inGiordana Pulpo(Co-Founder & Head of Design)inRitika Poddar(Cofounder)
Co-investorsRho Capital PartnersRho Ventures
Counsel develops AI solutions to expand clinical capacity in healthcare.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAndreessen HorowitzAsymmetric Capital PartnersFloodgateGV (Google Ventures)
Toronto-based generative AI company building text-to-image models known for accurate in-image text rendering.
Toronto, CA
William Chan(Founder)Mohammad Norouzi(Founder)in
Co-investorsAIX VenturesAndreessen HorowitzIndex VenturesRedpoint VenturesTwo Small Fish VenturesSV Angel
ResiQuant provides an AI-powered platform for property insurance underwriting, using AI agents that automate complex schedules, validate structural risk, and assess catastrophe perils such as earthquake, wildfire, windstorm, and flood.
AI & Machine LearningFintechInsurTechSaaSSan Francisco, US
Francisco Alfonso Galvis Lopez(Co-founder)Omar Issa(Co-founder)inFrancisco Galvis(Founder)in
BoardEvan Nisselson(Director)in
Co-investorsFoothill VenturesLDV CapitalAlumni Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.